Clinical trials

5

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Prospective, Multicenter, Single-Arm Study to Support the Clinical Evidence Base for MRace as a Treatment Option for FMR Patients With Complex M-TEER Anatomies (DE)

A pilot study to evaluate the safety and performance of the MRace System to treat severe mitral regurgitation and to gather data on its performance thereby providing guidance for future clinical development. The study is a single-arm registry with the last follow-up visit at 5 years post-intervention. The study will enroll up to 20 patients at 4 centers in Germany.

Participants needed: 20
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Polares Medical SAUpdated: Aug 11, 2026
Eligibility criteria

Patient has symptomatic moderate-to-severe to severe functional mitral regurgita... [+17]

Echocardiographic parameters (any of the following, assessed by the Echo Core La... [+44]

Status: Not yet recruiting

A Prospective, Multicenter, Single-Arm Study to Support the Clinical Evidence Base for MRace as a Treatment Option for FMR Patients With Complex M-TEER Anatomies (AU)

A pilot study to evaluate the safety and performance of the MRace System to treat severe mitral regurgitation and to gather data on its performance thereby providing guidance for future clinical development. The study is a single-arm registry with the last follow-up visit at 5 years post-intervention. The study will enroll up to 15 patients at 1 center in Australia

Participants needed: 15
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Polares Medical SAUpdated: Aug 11, 2026
Eligibility criteria

Patient has symptomatic moderate-to-severe to severe functional mitral regurgita... [+17]

Echocardiographic parameters (any of the following, assessed by the Echo Core La... [+44]

Status: Not yet recruiting

A Prospective, Multicenter, Single-Arm Study to Support the Clinical Evidence Base for MRace as a Treatment Option for FMR Patients With Complex M-TEER Anatomies (FR)

A pilot study to evaluate the safety and performance of the MRace System to treat severe mitral regurgitation and to gather data on its performance thereby providing guidance for future clinical development. The study is a single-arm registry with the last follow-up visit at 5 years post-intervention. The study will enroll up to 20 patients at 4 centers in France.

Participants needed: 20
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Polares Medical SAUpdated: Aug 11, 2026
Eligibility criteria

Patient has symptomatic moderate-to-severe to severe functional mitral regurgita... [+17]

Echocardiographic parameters (any of the following, assessed by the Echo Core La... [+44]

Status: Recruiting

EXPLORE MRace (BR): Early Feasibility Experience of Posterior Leaflet Restoration to Reduce Mitral Regurgitation Using the MRace Implant

An early feasibility study to evaluate the safety and feasibility of the MRace Implant and Delivery System to treat severe mitral regurgitation and to gather preliminary data on its performance thereby providing guidance for future clinical development. The study is a single-arm registry with the last follow-up visit at 5 years post-intervention. The study will enroll up to 10 patients at one (1) center in Brazil.

Participants needed: 10
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Polares Medical SAUpdated: Aug 10, 2026Locations: 1
Eligibility criteria

18 years of age or older [+6]

Severe tricuspid regurgitation [+30]

Status: Not yet recruiting

EFS of Posterior Leaflet Replacement to Reduce Mitral Regurgitation (United States)

The goal of this early feasibility clinical trial is to learn if the device MR-ace Implant and Delivery System works in patients with moderate or severe mitral valve regurgitation. It will also learn about the safety of the device MR-ace Implant and Delivery System. The main questions it aims to answer are: Does implanting the MR-ace device reduce the symptoms of mitral regurgitation? Does the device reduce the the leak through your mitral valve? Participants will: Be implanted with the device Visit the clinic for checkups and tests at 30 days, 6 months, 12 months, and 2, 3, 4 and 5 years following your procedure Complete a quality of life survey

Participants needed: 15
Trial details
Age: 21+Biological sex: AllType: InterventionalSponsor: Polares Medical SAUpdated: Apr 8, 2026
Eligibility criteria

Patient has symptomatic moderate-to-severe to severe functional mitral regurgita... [+10]

Echocardiographic parameters (any of the following, assessed by the Echo Core La... [+36]